Histamine H1 Receptor: A potential therapeutic target for pancreatic ductal adenocarcinoma.
Saved in:
| Title: | Histamine H1 Receptor: A potential therapeutic target for pancreatic ductal adenocarcinoma. |
|---|---|
| Authors: | Salmerón C; Department of Pharmacology, University of California, San Diego, La Jolla, California., Tomás Bort E; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom; Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom., Sriram K; Department of Pharmacology, University of California, San Diego, La Jolla, California., Javadi-Paydar M; Department of Pharmacology, University of California, San Diego, La Jolla, California., Smitham JE; Department of Pharmacology, University of California, San Diego, La Jolla, California., Pham K; Department of Pharmacology, University of California, San Diego, La Jolla, California., Grose RP; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., McCormick PJ; Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom., DiNardo A; Department of Dermatology, University of California San Diego, La Jolla, California., Weitz J; Department of Surgery, Division of Surgical Oncology, Moores Cancer Center, University of California, San Diego, La Jolla, California., Tiriac H; Department of Surgery, Division of Surgical Oncology, Moores Cancer Center, University of California, San Diego, La Jolla, California., Lowy AM; Department of Surgery, Division of Surgical Oncology, Moores Cancer Center, University of California, San Diego, La Jolla, California., Insel PA; Department of Pharmacology, University of California, San Diego, La Jolla, California. Electronic address: pinsel@health.ucsd.edu. |
| Source: | The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2025 May; Vol. 392 (5), pp. 103573. Date of Electronic Publication: 2025 Apr 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0376362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0103 (Electronic) Linking ISSN: 00223565 NLM ISO Abbreviation: J Pharmacol Exp Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40288207 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Histamine H1 Receptor: A potential therapeutic target for pancreatic ductal adenocarcinoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Salmerón+C%22">Salmerón C</searchLink>; Department of Pharmacology, University of California, San Diego, La Jolla, California.<br /><searchLink fieldCode="AU" term="%22Tomás+Bort+E%22">Tomás Bort E</searchLink>; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom; Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Sriram+K%22">Sriram K</searchLink>; Department of Pharmacology, University of California, San Diego, La Jolla, California.<br /><searchLink fieldCode="AU" term="%22Javadi-Paydar+M%22">Javadi-Paydar M</searchLink>; Department of Pharmacology, University of California, San Diego, La Jolla, California.<br /><searchLink fieldCode="AU" term="%22Smitham+JE%22">Smitham JE</searchLink>; Department of Pharmacology, University of California, San Diego, La Jolla, California.<br /><searchLink fieldCode="AU" term="%22Pham+K%22">Pham K</searchLink>; Department of Pharmacology, University of California, San Diego, La Jolla, California.<br /><searchLink fieldCode="AU" term="%22Grose+RP%22">Grose RP</searchLink>; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22McCormick+PJ%22">McCormick PJ</searchLink>; Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom.<br /><searchLink fieldCode="AU" term="%22DiNardo+A%22">DiNardo A</searchLink>; Department of Dermatology, University of California San Diego, La Jolla, California.<br /><searchLink fieldCode="AU" term="%22Weitz+J%22">Weitz J</searchLink>; Department of Surgery, Division of Surgical Oncology, Moores Cancer Center, University of California, San Diego, La Jolla, California.<br /><searchLink fieldCode="AU" term="%22Tiriac+H%22">Tiriac H</searchLink>; Department of Surgery, Division of Surgical Oncology, Moores Cancer Center, University of California, San Diego, La Jolla, California.<br /><searchLink fieldCode="AU" term="%22Lowy+AM%22">Lowy AM</searchLink>; Department of Surgery, Division of Surgical Oncology, Moores Cancer Center, University of California, San Diego, La Jolla, California.<br /><searchLink fieldCode="AU" term="%22Insel+PA%22">Insel PA</searchLink>; Department of Pharmacology, University of California, San Diego, La Jolla, California. Electronic address: pinsel@health.ucsd.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220376362%22">The Journal of pharmacology and experimental therapeutics</searchLink> [J Pharmacol Exp Ther] 2025 May; Vol. 392 (5), pp. 103573. <i>Date of Electronic Publication: </i>2025 Apr 04. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>0376362 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1521-0103 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200223565%22">00223565 </searchLink><i>NLM ISO Abbreviation: </i>J Pharmacol Exp Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40288207 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jpet.2025.103573 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 103573 Titles: – TitleFull: Histamine H1 Receptor: A potential therapeutic target for pancreatic ductal adenocarcinoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Salmerón C – PersonEntity: Name: NameFull: Tomás Bort E – PersonEntity: Name: NameFull: Sriram K – PersonEntity: Name: NameFull: Javadi-Paydar M – PersonEntity: Name: NameFull: Smitham JE – PersonEntity: Name: NameFull: Pham K – PersonEntity: Name: NameFull: Grose RP – PersonEntity: Name: NameFull: McCormick PJ – PersonEntity: Name: NameFull: DiNardo A – PersonEntity: Name: NameFull: Weitz J – PersonEntity: Name: NameFull: Tiriac H – PersonEntity: Name: NameFull: Lowy AM – PersonEntity: Name: NameFull: Insel PA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2025 May Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1521-0103 Numbering: – Type: volume Value: 392 – Type: issue Value: 5 Titles: – TitleFull: The Journal of pharmacology and experimental therapeutics Type: main |
| ResultId | 1 |